Per Svensson

ORCID: 0000-0003-0372-6272
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Blood Pressure and Hypertension Studies
  • Advanced Database Systems and Queries
  • Genetic Associations and Epidemiology
  • Cardiac Imaging and Diagnostics
  • Data Management and Algorithms
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Data Mining Algorithms and Applications
  • Peripheral Artery Disease Management
  • Cardiovascular Health and Disease Prevention
  • COVID-19 Clinical Research Studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Health and Mental Health
  • Target Tracking and Data Fusion in Sensor Networks
  • Emergency and Acute Care Studies
  • Chronic Kidney Disease and Diabetes
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Health and Risk Factors
  • Birth, Development, and Health
  • Genetics and Neurodevelopmental Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Data Quality and Management

Karolinska Institutet
2016-2025

Stockholm South General Hospital
2018-2025

Karolinska University Hospital
2009-2021

Uppsala University
2018

Danderyds sjukhus
2018

Dalarna University
2015

Medical Products Agency
2015

Kent State University
2014

Swedish Defence Research Agency
1976-2009

Institute for Environmental Management
2008

In the HOPE-trial, ACE inhibitor ramipril significantly reduced cardiovascular morbidity and mortality in patients at high risk for events. The benefit could only partly be attributed to modest mean reduction of office blood pressure (OBP) during study period (3/2 mm Hg). However, because according HOPE protocol was given once daily bedtime measured day, 24-hour may underestimated based on OBP. Thirty-eight with peripheral arterial disease enrolled underwent ambulatory (ABP) measurement...

10.1161/hy1101.099502 article EN Hypertension 2001-12-01

Epidemiological studies show that high circulating cystatin C is associated with risk of cardiovascular disease (CVD), independent creatinine-based renal function measurements. It unclear whether this relationship causal, arises from residual confounding, and/or a consequence reverse causation. The aim study was to use Mendelian randomization investigate causally related CVD in the general population. We incorporated participant data 16 prospective cohorts (n = 76,481) 37,126 measures and...

10.1016/j.jacc.2016.05.092 article EN cc-by-nc-nd Journal of the American College of Cardiology 2016-08-01

Background: The comparative efficacy and safety of ticagrelor versus clopidogrel in older patients with myocardial infarction (MI) has received limited study. Methods: We performed an observational analysis all ≥80 years (n=14 005) who were discharged alive aspirin combined either (60.2%) or (39.8%) after a MI between 2010 2017 registered the national registry SWEDEHEART (Swedish Web-System for Enhancement Development Evidence-Based Care Heart Disease Evaluated According to Recommended...

10.1161/circulationaha.120.050645 article EN Circulation 2020-09-01

Decreased renal function is an established risk factor for cardiovascular disease (CVD). Causal mechanisms between estimates of and CVD are intricate investigation the relative importance genetic environmental factors variability these phenotypes could provide new knowledge.Cystatin C creatinine levels in 12 313 twins were analyzed. Uni- bivariate heritability traits was estimated through structured equation modelling genome-wide complex trait analysis (GCTA) order to independently confirm...

10.1161/jaha.114.001467 article EN cc-by-nc-nd Journal of the American Heart Association 2015-01-05

Background: The number of patients with myocardial infarction and severe obesity is increasing there a lack evidence how these should be treated. aim this study was to investigate the association between metabolic surgery (Roux-en-Y gastric bypass sleeve gastrectomy) major adverse cardiovascular events in previous (MI) obesity. Methods: Of 566 MI registered SWEDEHEART registry (Swedish Web-System for Enhancement Development Evidence-Based Care Heart Disease Evaluated According Recommended...

10.1161/circulationaha.120.048585 article EN Circulation 2020-10-26

Background Risk assessment post-myocardial infarction needs improvement, and risk factors derived from general populations apply differently in secondary prevention. The prediction of subsequent cardiovascular events by socioeconomic status has previously been poorly studied. Design Swedish nationwide cohort study. Methods A total 29,226 men women (27%), 40–76 years age, registered at the standardised one year revisit after a first myocardial prevention quality registry SWEDEHEART 2006–2014....

10.1177/2047487318766646 article EN European Journal of Preventive Cardiology 2018-04-17

Aims The risks associated with diabetes, obesity and hypertension for severe COVID-19 may be confounded differ by sociodemographic background. We assessed the cardiometabolic factors when accounting socioeconomic in subgroups age, sex region of birth. Methods results In this nationwide case–control study, 1.086 patients admitted to intensive care requiring mechanical ventilation (cases), 10.860 population-based controls matched district residency were included from mandatory national...

10.1136/bmjopen-2020-044486 article EN cc-by-nc-nd BMJ Open 2021-02-01

The association between abdominal obesity and recurrent atherosclerotic cardiovascular disease after myocardial infarction remains unknown.The purpose of this study was to investigate the prevalence its with in patients a first infarction.In register-based observational cohort, 22,882 were identified from national Swedish Web-system for Enhancement Development Evidence-based Care Heart Disease Evaluated According Recommended Therapies (SWEDEHEART) registry at clinical revisit 4-10 weeks...

10.1177/2047487319898019 article EN European Journal of Preventive Cardiology 2020-01-21

Low socioeconomic status (SES) is associated with poor long-term prognosis after myocardial infarction (MI). Plausible underlying mechanisms have received limited study.To assess whether SES risk factor target achievements or risk-modifying activities, including cardiac rehabilitation programs, monitoring, and drug therapies, during the first year MI.This cohort study included a population-based consecutive sample of 30 191 one-year survivors first-ever MI who were 18 to 76 years age,...

10.1001/jamanetworkopen.2021.1129 article EN cc-by-nc-nd JAMA Network Open 2021-03-10

In twin studies of cardiovascular disease biomarkers the dizygotic correlations are often estimated to be less than half monozygotic indicating a potential influence nonadditive genetic factors. Using large and homogenous sample, we additive dominance influences on levels high density lipoprotein, low apolipoprotein A-I, B, total cholesterol, triglycerides, glucose, hemoglobin Alc c-reactive protein, all which associated with disease. The blood were measured 12,000 Swedish twins born between...

10.1375/twin.12.3.286 article EN Twin Research and Human Genetics 2009-05-20

In the emergency department (ED), high blood pressure (BP) is commonly observed but mostly used to evaluate patients' health in short term. We aimed study whether ED-measured BP associated with incident atherosclerotic cardiovascular disease (ASCVD), myocardial infarction, or stroke long term, and estimate number needed screen prevent ASCVD. this cohort study, participants were selected from a university hospital between 2010 2016, an obtained ED. The outcome information was acquired through...

10.1161/hypertensionaha.119.14002 article EN cc-by-nc-nd Hypertension 2019-12-02

Abstract Aims We aimed to investigate whether metabolomic profiling of blood can lead novel insights into heart failure pathogenesis or improved risk prediction. Methods and results Mass spectrometry‐based was performed in plasma serum samples from three community‐based cohorts without at baseline (total n = 3924; 341 incident events; median follow‐up ranging 4.6 13.9 years). Cox proportional hazard models were applied assess the association each 206 identified metabolites with discovery...

10.1002/ehf2.12453 article EN cc-by-nc ESC Heart Failure 2019-05-30

The value of family history coronary artery disease (CAD) in diagnosing acute syndrome (ACS) chest pain patients is uncertain, especially relation to high-sensitivity assays for cardiac troponin T (hs-cTnT), which have improved ACS diagnostics. Our objective was investigate the association between verified CAD and patients, overall different strata initial hs-cTnT.Data on visiting four emergency departments Sweden during 2013-2016 were cross-referenced with national registers kinship,...

10.1177/2048872619853521 article EN European Heart Journal Acute Cardiovascular Care 2019-05-24

Abstract To determine whether immigrant background and socioeconomic status were associated with increased risk to develop severe Coronavirus disease 2019 (COVID-19) requiring mechanical ventilation at the intensive care unit study their effects on 90-day mortality. Nationwide case–control personal-level data from Swedish Intensive Care register linked Statistics Sweden comorbidity national patient register. For each case of COVID-19 treated (outcome), 10 population controls matched for age,...

10.1038/s41598-022-15884-2 article EN cc-by Scientific Reports 2022-07-15
R. Thomas Lumbers Sonia Shah Honghuang Lin Tomasz Czuba Albert Henry and 95 more Daniel I. Swerdlow Anders Mälarstig Charlotte Andersson Niek Verweij Michael V. Holmes Johan Ärnlöv Per Svensson Harry Hemingway Neneh Sallah Peter Almgren Krishna G. Aragam Géraldine Asselin Joshua Backman Mary L. Biggs Heather L. Bloom Eric Boersma Jeffrey Brandimarto Michael R. Brown Hans‐Peter Brunner‐La Rocca David J. Carey Mark Chaffin Daniel I. Chasman Olympe Chazara Xing Chen Xu Chen Jonathan H. Chung William A. Chutkow John G.F. Cleland James P. Cook Simon de Denus Abbas Dehghan Graciela E. Delgado Spiros Denaxas Alex S. F. Doney Marcus Dörr Samuel C. Dudley Gunnar Engström Tõnu Esko Ghazaleh Fatemifar Stephan B. Felix Chris Finan Ian Ford Françoise Fougerousse René Fouodjio Mohsen Ghanbari Sahar Ghasemi Vilmantas Giedraitis Franco Giulianini John S. Gottdiener Stefan Groß Daníel F. Guðbjartsson Hongsheng Gui Rebecca Gutmann Christopher M. Haggerty Pim van der Harst Åsa K. Hedman Anna Helgadóttir Hans L. Hillege Craig Hyde Jaison Jacob J. Wouter Jukema Frederick Kamanu Isabella Kardys Maryam Kavousi Kay‐Tee Khaw Marcus E. Kleber Lars Køber Andrea Koekemoer Bill Kraus Karoline Kuchenbaecker Claudia Langenberg Lars Lind Cecilia M. Lindgren Barry London Luca A. Lotta Ruth C. Lovering Jian’an Luan Patrik K. E. Magnusson Anubha Mahajan Douglas L. Mann Kenneth B. Margulies Nicholas Marston Winfried März John J.V. McMurray Olle Melander Giorgio Melloni Ify Mordi Michael P. Morley Andrew D. Morris Andrew P. Morris Alanna C. Morrison Michael W. Nagle Christopher P. Nelson Christopher Newton‐Cheh Alexander Niessner

Abstract Aims The HERMES (HEart failure Molecular Epidemiology for Therapeutic targetS) consortium aims to identify the genomic and molecular basis of heart failure. Methods results currently includes 51 studies from 11 countries, including 68 157 cases 949 888 controls, with data on events prognosis. All collected biological samples performed genome‐wide genotyping common genetic variants. enrolment subjects into participating ranged 1948 present day, median follow‐up following diagnosis 2...

10.1002/ehf2.13517 article EN cc-by ESC Heart Failure 2021-09-03
Coming Soon ...